Estimating Seroprevalence of Vaccine-Preventable Infections: Is It Worth Standardizing the Serological Outcomes to Adjust for Different Assays and Laboratories?
Epidemiology and Infection - United Kingdom
doi 10.1017/s095026881400301x
Full Text
Open PDFAbstract
Available in full text
Date
November 25, 2014
Authors
Publisher
Cambridge University Press (CUP)